PALO ALTO, Calif. and MIAMI, July 20, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. KTTA (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, today confirmed that an independent special committee (“Special Committee”) of its Board…Read More
Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery Inc Pasithea Therapeutics NASDAQKTTA Pasithea Therapeutics NASDAQKTTAW
